The lump in the left breast had reached approximately 5 cm. A biopsy revealed malignancy, classified as intraductal carcinoma. Mrs. Sri Wahyuni was adamant about not undergoing surgery. She wanted to use only the ECCT device. However, her cancer type wasn’t one that could dissolve and exit the body through sweat, urine, or bowel movements. She consulted nearly all oncologists in Medan and Malaysia who would support her use of the ECCT device and were willing to perform only a lumpectomy (BCT). However, no doctors agreed. They all insisted she should undergo a mastectomy, removing the entire left breast. Eventually, a surgical oncologist in Jakarta agreed to perform a lumpectomy, and a young oncologist in Medan supported her use of ECCT and was willing to administer radiation at the BCT surgery site. A year later, there was some spread to the lungs, but the nodules disappeared with the use of the device alone. Mrs. Sri Wahyuni has now lived 10 years since her cancer diagnosis in 2023, in good health and in remission (cancer-free).
Image: RIGHT: An ultrasound image showing a 4 cm nodule in the left breast along with breast electrical activity based on a Breast ECVT scan; CENTER: A PET CT scan showing a mass in the breast that has cleared, a lesion in the lungs with low activity (likely an original nodule undergoing cell death through the use of the device), with no spread to other organs; LEFT: Mrs. Sri Wahyuni’s condition after 10 years, cancer-free and in good health
Mrs. Sri Wahyuni was diagnosed with breast cancer in October 2013. The ultrasound showed a lump measuring 4×2.5×2 cm. The FNAB biopsy confirmed malignancy, classified as intraductal carcinoma or Ductal Carcinoma in Situ (DCIS). Her doctor advised a mastectomy (removal of the entire breast), followed by chemotherapy and radiation.
Determined to avoid a mastectomy, Mrs. Sri Wahyuni consulted C-Care Research to see if she could use the ECCT device instead of surgery. An ECVT scan at C-Care Research showed a maximum breast electrical activity index of 0.35, indicating cancer of moderate to low malignancy. Based on the cancer cell type and response to ECCT, her cancer was classified as Type D. The general response to ECCT therapy was also moderate—neither too fast nor too slow. The cells dying from the therapy tended to accumulate around the tumor area, with slow waste disposal, so the mass size generally increased, especially during the first six months of use. For this type, a combination with surgery was usually recommended. In many cases, surgery only involved removing the lump after 3-4 months of using the device, when the main mass had weakened, and small metastases had cleared.
Mrs. Sri Wahyuni decided to use the ECCT device, hoping that her cancer would dissolve and exit her body through sweat, urine, or bowel movements, thus eliminating the cancer without surgery. However, her therapy progress aligned more closely with the analysis and predictions of C-Care’s Medical Physics team. Cancer Type D wouldn’t exit the body through natural waste processes like sweat or urine. After about a year of using the device, the lump softened, the electrical activity based on the ECVT scan decreased, but its size relatively increased. X-ray and abdominal ultrasound results were clear, with no evidence of metastasis. Overall, the therapy’s one-year progress indicated a localized tumor mass, softened with no spread, decreased activity, and only an increase in size. The C-Care team advised Mrs. Sri Wahyuni to consult a surgeon willing to perform the operation. She agreed to surgery only if it involved removing just the lump.
She returned to her oncologist in Medan for a consultation about lumpectomy (lump removal) surgery. “There’s no such medical protocol. It’s either mastectomy, followed by chemo or radiation,” the doctor responded. Dissatisfied with this response, Mrs. Sri Wahyuni sought other doctors. Every doctor she visited in Medan gave her the same answer. Still hoping to find a doctor willing to follow her wishes, Mrs. Sri Wahyuni traveled to Malaysia. All the oncologists she consulted there gave similar responses to those in Medan.
She remained firm in her decision not to undergo surgery if it meant removing her entire breast. Eventually, she met a young oncologist in Medan who had a strong interest in ECCT. The doctor respected her wish to undergo lumpectomy only and supported her continued use of ECCT, promising to help her with radiation after the lumpectomy. In early 2016, Mrs. Sri Wahyuni finally found a surgical oncologist in Jakarta who agreed to perform the lumpectomy. She then underwent radiation in Medan starting mid-2016.
After the lumpectomy and radiation, the lump in her breast was gone, and the keloid that had developed at the surgical site also disappeared with radiation. She continued to use the ECCT vest after surgery and radiation. In early 2017, a PET CT scan revealed a low-activity nodule in her lungs, a year after the surgery. The metastasis likely occurred during the surgery. However, with the continued use of the device, the spread was contained, and the activity gradually decreased. She continued using only the ECCT device.
Her 2024 check-up, marking 10 years since her initial cancer diagnosis, showed everything was clear. She remains healthy, cancer-free, and active. After 10 years of remission, Mrs. Sri Wahyuni has switched to using the ECBS device for exercise and preventive purposes. We wish Mrs. Sri Wahyuni continued health and vitality.
